编者按：在今年的AATS Focus on Thoracic Surgery: Lung and Esophageal Cancer 会议上，来自梅奥诊所的Stephen D. Cassivi教授精彩的报告中，穿插了一些富有中国味的元素与观众进行互动，颇为有趣，他借用白求恩与中国的友好关系寄望中外医生的友好交流。趁此机会，笔者邀请了他与来自四川大学华西医院胸外科的刘伦旭教授——单向式胸腔镜手术的开拓者，进行一场中外对话，讨论至今仍被热议的SBRT Versus Surgery等颇有争议性的话题。
Q1: Surgery Versus SBRT? The treatment of early stage lung cancer has been a controversial topic. What is your opinion?
Q2: There was a lung symposium discussing the differences of education of young thoracic surgeons between North America, China and Europe. How do you see the differences? How do you think to better educate them?
Q3: You may have heard that recently the computer AlphaGo won in a Go-chess showdown against the world's top player. Some people say artificial intelligence may replace many roles of human in the future, including surgeons. How do you think?
Stephen D. Cassivi, MD, MSc, FRCSC, FACS
Division of General Thoracic Surgery, Mayo Clinic, Rochester, Minnesota, USA
Prof. Stephen Cassivi completed his General Surgery residency at the University of Toronto, Canada and was certified by the Royal College of Physicians and Surgeons of Canada. He also obtained certification from the American Board of Surgery. Following his training in St. Louis, Dr. Cassivi accepted a position in the Division of General Thoracic Surgery at Mayo Clinic in Rochester, Minnesota, where he has holds the academic rank of Professor of Surgery. Dr. Cassivi served as Surgical Director of the Lung Transplantation Program at Mayo Clinic from 2004-2012. In 2013, Dr. Cassivi was appointed as Vice Chair of the Department of Surgery with responsibilities and oversight of the clinical practice.